Maridea Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$487K Buy
406
+52
+15% +$53.1K 0.05% 307
2026
Q1
$325K Sell
354
-320
-47% -$324K 0.05% 327
2025
Q4
$724K Buy
674
+361
+115% +$345K 0.11% 188
2025
Q3
$253K Buy
+313
New +$233K 0.04% 352
2025
Q2
Sell
-303
Closed -$250K 298
2025
Q1
$250K Sell
303
-23
-7% -$19.1K 0.08% 192
2024
Q4
$252K Buy
+326
New +$270K 0.08% 199

Other funds holding LLY

Maridea Wealth Management's LLY Position: Q2 2026 in Review

Maridea Wealth Management increased its Eli Lilly (LLY) stake by 15% in Q2 2026, buying an estimated $53.1K and bringing the position to 406 shares worth $487K. The position accounts for 0.05% of the portfolio, ranked #307.

Maridea Wealth Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $724K in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Maridea Wealth Management held 406 shares of Eli Lilly worth $487K as of Q2 2026.
  • Maridea Wealth Management bought 52 Eli Lilly shares in Q2 2026, an estimated $53.1K.
  • Eli Lilly made up 0.05% of Maridea Wealth Management's portfolio in Q2 2026, its #307 holding.
  • Maridea Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Maridea Wealth Management's Eli Lilly position peaked at $724K in Q4 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Maridea Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.